Lijun Xie

500 total citations
41 papers, 326 citations indexed

About

Lijun Xie is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Lijun Xie has authored 41 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Lijun Xie's work include Diabetes Treatment and Management (6 papers), Gastroesophageal reflux and treatments (5 papers) and Diabetes Management and Research (4 papers). Lijun Xie is often cited by papers focused on Diabetes Treatment and Management (6 papers), Gastroesophageal reflux and treatments (5 papers) and Diabetes Management and Research (4 papers). Lijun Xie collaborates with scholars based in China, Finland and Saudi Arabia. Lijun Xie's co-authors include Feng Shao, Sufeng Zhou, Yun Liu, Juan Chen, Sijia Ding, Juan Chen, Hongwen Zhang, Ning Ou, Yongqing Wang and Xue‐Hui Zhang and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Remote Sensing.

In The Last Decade

Lijun Xie

38 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lijun Xie China 12 92 75 60 50 41 41 326
Milan Dastych Czechia 12 96 1.0× 49 0.7× 89 1.5× 63 1.3× 24 0.6× 52 445
Srikanth Sridhar United States 10 98 1.1× 94 1.3× 46 0.8× 12 0.2× 21 0.5× 28 394
Jyh-Chang Hwang Taiwan 12 83 0.9× 57 0.8× 43 0.7× 24 0.5× 20 0.5× 27 382
Kyungho Lee South Korea 12 78 0.8× 41 0.5× 92 1.5× 26 0.5× 17 0.4× 42 353
Simone Gonçalves Brazil 10 70 0.8× 56 0.7× 106 1.8× 20 0.4× 14 0.3× 14 496
CD Heidecke Germany 11 176 1.9× 77 1.0× 41 0.7× 55 1.1× 19 0.5× 28 402
Dirk H. S. M. Schellekens Netherlands 9 198 2.2× 90 1.2× 49 0.8× 39 0.8× 19 0.5× 11 381
Murat Akarsu Türkiye 9 107 1.2× 38 0.5× 37 0.6× 36 0.7× 9 0.2× 34 315
Péter Lipták Slovakia 8 74 0.8× 38 0.5× 49 0.8× 39 0.8× 13 0.3× 25 296
Nageshwara Gullapalli United States 11 87 0.9× 90 1.2× 37 0.6× 128 2.6× 20 0.5× 47 436

Countries citing papers authored by Lijun Xie

Since Specialization
Citations

This map shows the geographic impact of Lijun Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijun Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijun Xie more than expected).

Fields of papers citing papers by Lijun Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijun Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijun Xie. The network helps show where Lijun Xie may publish in the future.

Co-authorship network of co-authors of Lijun Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Lijun Xie. A scholar is included among the top collaborators of Lijun Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijun Xie. Lijun Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yanfeng, Ziyan Xu, Lijun Xie, et al.. (2025). Fasudil targets the RhoA/ROCK-NLRP3 axis to attenuate aristolochic acid-induced renal pyroptosis: translational validation by in vivo molecular imaging. International Immunopharmacology. 168(Pt 2). 115888–115888.
2.
Xie, Lijun, Mo Chen, Wei Pan, et al.. (2024). Imaging features of hepatic angiosarcoma: retrospective analysis of two centers. BMC Cancer. 24(1). 1191–1191. 2 indexed citations
3.
Xie, Lijun, et al.. (2023). Ilizarov method and its combined methods in the treatment of long bone defects of the lower extremity: systematic review and meta-analysis. BMC Musculoskeletal Disorders. 24(1). 891–891. 12 indexed citations
4.
Zhou, Sufeng, Lijun Xie, Yuqing Zhao, et al.. (2023). Safety, Pharmacokinetics, and Pharmacodynamics of Midazolam Gel After Rectal Administration in Healthy Chinese Subjects. Clinical Drug Investigation. 43(6). 421–433. 1 indexed citations
5.
Wang, Bin, Yuqi Fu, Lijun Xie, et al.. (2023). Measurement of urinary exosomal phospholipase A2 receptor is a sensitive method for diagnosis of PLA2R-associated membranous nephropathy. Clinical Kidney Journal. 17(1). sfad191–sfad191. 3 indexed citations
6.
Zhou, Sufeng, Lijun Xie, Juan Chen, et al.. (2023). Keverprazan, a novel potassium‐competitive acid blocker: Multiple oral doses safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects. Clinical and Translational Science. 16(10). 1911–1922. 13 indexed citations
7.
Xie, Lijun, et al.. (2022). The Multimodal Ultrasound Features of Ovarian Serous Surface Papillary Borderline Tumor. Women s Health Reports. 3(1). 523–532. 2 indexed citations
8.
Ding, Sijia, Lijun Xie, Lu Wang, et al.. (2022). Pharmacokinetic Interaction of Anaprazole, Amoxicillin and Clarithromycin after Single-Dose Simultaneous Administration and the Effect of Adding Bismuth on Their Pharmacokinetics in Healthy Male Chinese Subjects. European Journal of Drug Metabolism and Pharmacokinetics. 48(2). 121–132. 3 indexed citations
9.
Zhao, Yuqing, Lijun Xie, Hongwen Zhang, et al.. (2022). Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of SY-004, a Glucokinase Activator, in Healthy Chinese Adults: A Randomized, Phase Ia, Single-Ascending Dose Study. Clinical Therapeutics. 44(2). 269–281. 2 indexed citations
10.
Huang, Liyan, et al.. (2021). The Value of Relative Size in the Ultrasound Diagnosis of Follicular Thyroid Neoplasm. International Journal of General Medicine. Volume 14. 2321–2328. 2 indexed citations
11.
Jiang, Lei, Lijun Xie, Ge Li, et al.. (2021). Clinical characteristics and surgical treatments of primary hepatic angiosarcoma. BMC Gastroenterology. 21(1). 156–156. 15 indexed citations
12.
13.
Li, Haiying, et al.. (2020). Diagnostic accuracy and cut-off of contrast-enhanced ultrasound in caesarean scar pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 246. 117–122. 15 indexed citations
14.
Zhou, Sufeng, Wei Liu, Chen Zhou, et al.. (2020). Mass balance, metabolic disposition, and pharmacokinetics of [14C]ensartinib, a novel potent anaplastic lymphoma kinase (ALK) inhibitor, in healthy subjects following oral administration. Cancer Chemotherapy and Pharmacology. 86(6). 719–730. 1 indexed citations
15.
Zhang, Xue‐Hui, Jie Liu, Luning Sun, et al.. (2019). Effects of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of proton pump inhibitors. Pharmacological Research. 152. 104606–104606. 32 indexed citations
16.
Cao, Yang, Yue-Qi Li, Hongwen Zhang, et al.. (2017). Impact of Gastric H+/K+-ATPase rs2733743 on the Intragastric pH-Values of Dexlansoprazole Injection in Chinese Subjects. Frontiers in Pharmacology. 8. 670–670. 7 indexed citations
17.
Shao, Feng, Hongwen Zhang, Lijun Xie, et al.. (2017). Pharmacokinetics of ginkgolides A, B and K after single and multiple intravenous infusions and their interactions with midazolam in healthy Chinese male subjects. European Journal of Clinical Pharmacology. 73(5). 537–546. 13 indexed citations
18.
Sang, Shaowei, Zhongtang Zhao, Jijiang Suo, et al.. (2014). Report of Recombinant Norovirus GII.g/GII.12 in Beijing, China. PLoS ONE. 9(2). e88210–e88210. 15 indexed citations
19.
Wen, Hongmei, Zulin Dou, Sulin Cheng, et al.. (2014). Activity of Thigh Muscles During Static and Dynamic Stances in Stroke Patients: A Pilot Case-Control Study. Topics in Stroke Rehabilitation. 21(2). 163–172. 7 indexed citations
20.
Jia, Na, Jijiang Suo, Yubin Xing, et al.. (2011). Perinatal outcomes and congenital abnormalities in the newborns of women affected by the 2009 pandemic influenza A (H1N1) in Beijing, China. International Journal of Gynecology & Obstetrics. 116(2). 148–152. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Milan Dastych Breakdown of academic impact, for papers by Srikanth Sridhar Breakdown of academic impact, for papers by Jyh-Chang Hwang Breakdown of academic impact, for papers by Kyungho Lee Breakdown of academic impact, for papers by Simone Gonçalves Breakdown of academic impact, for papers by CD Heidecke Breakdown of academic impact, for papers by Dirk H. S. M. Schellekens Breakdown of academic impact, for papers by Murat Akarsu Breakdown of academic impact, for papers by Péter Lipták Breakdown of academic impact, for papers by Nageshwara Gullapalli
Rankless by CCL
2026